Autoimmune Diseases and Immune Modulation: Current Research and Future Outlook
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Immunology and Immunotherapy".
Deadline for manuscript submissions: 31 May 2024 | Viewed by 87
Special Issue Editors
Interests: immunodeficiency; immune-mediated diseases; biologics; pharmacogenomics; vaccines
Special Issues, Collections and Topics in MDPI journals
Interests: mediators of inflammation, cytokines, and biomarkers of oxidative stress; immunosenescence; immunogenetics; epigenetics; application of machine learning and deep learning in various fields of medicine
Special Issues, Collections and Topics in MDPI journals
Interests: immunosenescence
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Autoimmune diseases (ADs), such as rheumatoid arthritis (RA), Sjogren's disease (SS) and Systemic Lupus Erythematosus (SLE), have a significant impact on patients’ quality of life and impose significant economic and psychological burdens on society and families. For this reason, in recent years, the attention has focused on the etiological and pathogenetic mechanisms underlying these immune disorders, with particular reference to the possible mechanisms of immune modulation and potential therapeutic targets. In this field, molecules, such as CAR (Chimeric Antigen Receptor), Treg cells, Sirtuin 1 (SIRT1), exosomes, gut microbiota dysbiosis, vitamin D, macrophages and neutrophils in innate and adaptive immunity conditions have acquired growing interest.
Studying these molecules plays an important role in representing not only potential diagnostic markers, but also possible targets for the immune-modulation therapy of autoimmune disorders.
Prof. Giuseppe Murdaca
Prof. Dr. Sebastiano Gangemi
Dr. Francesca Paladin
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- CAR and immune system
- Treg cells and immune system
- SIRT1 and immune system
- exosomes and immune system
- gut microbiota dysbiosis and immune system
- vitamin D and immune system
- macrophages/neutrophils and immune system
- CAR and autoimmune diseases
- Treg cells and autoimmune diseases
- SIRT1 and autoimmune diseases
- exosomes and autoimmune diseases
- gut microbiota dysbiosis and autoimmune diseases
- vitamin D and autoimmune diseases
- macrophages/neutrophils and autoimmune diseases
- EIcircRNAs and autoimmune diseases
